Internal Medicine — Old Senior Academic Day Lectures (Until Sep 2023)
Interstitial lung disease: evaluation and treatment
EPAs mapped to this activity
None.
Competencies covered in this activity
| 1. Practise medicine within their defined scope of practice and expertise | ||||||
| 1.3. Apply knowledge of the clinical and biomedical sciences relevant to Internal Medicine | ||||||
| 1.3.8. Pharmacology as it relates to pharmacokinetics, pharmacodynamics, mechanism of action, routes of delivery and elimination, and adverse effects of medications | ||||||
| 1.3.8.1. Analgesics | ||||||
| 1.3.8.2. Antimicrobials | ||||||
| 1.3.8.3. Cardiovascular medications | ||||||
| 1.3.8.4. Endocrine medications | ||||||
| 1.3.8.5. Immune modulating therapies | ||||||
| 1.3.8.6. Neuropsychiatric medications | ||||||
| 1.3.8.7. Respiratory medications | ||||||
| 1.3.8.8. Systemic therapies for cancer | ||||||
| 1.3.8.9. Drugs commonly used recreationally | ||||||
| 1.3.8.10. Supplementary and complementary medications | ||||||
| 1.4. Apply knowledge of the following systems, clinical scenarios, conditions, diseases and therapies applicable to Internal Medicine, including the manifestations, investigation, and management | ||||||
| 1.4.3. Respiratory | ||||||
| 1.4.3.1. Symptoms | ||||||
| 1.4.3.1.1. Acute and chronic dyspnea | ||||||
| 1.4.3.1.2. Cough | ||||||
| 1.4.3.1.3. Hemoptysis | ||||||
| 1.4.3.1.4. Wheeze | ||||||
| 1.4.3.2. Findings and investigations | ||||||
| 1.4.3.2.1. Interpretation of pulmonary function testing | ||||||
| 1.4.3.3. Disorders | ||||||
| 1.4.3.3.1. Bronchial asthma | ||||||
| 1.4.3.3.2. Chronic obstructive lung disease | ||||||
| 1.4.3.3.3. Interstitial lung disease | ||||||
| 1.4.3.3.4. Pleural effusion | ||||||
| 1.4.3.3.5. Pneumonia | ||||||
| 1.4.3.3.6. Pneumothorax | ||||||
| 1.4.3.3.7. Pulmonary embolism | ||||||
| 1.4.3.3.8. Sarcoidosis | ||||||
| 1.4.3.3.9. Lung neoplasms: primary and metastatic, including paraneoplastic syndromes | ||||||
Training experiences included in this activity
None.